As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less processed foods and soda, researchers say food and beverage companies are adjusting strategies. The results of a national study conducted by the Arkansas Agricultural Experiment Station found that these weight-loss drugs—known as glucagon-like peptide-1 agonists or GLP-1s—lead to new food and drink consumption patterns, which underscore observed changes in, Read more